Gastrointestinal Stromal Tumor Global Market Report 2025

Global Gastrointestinal Stromal Tumor Market Report 2024

Gastrointestinal Stromal Tumor Global Market Report 2025 – By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Indication (Stomach, Small Intestine, Others Indications), By End-User (Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Gastrointestinal Stromal Tumor Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Gastrointestinal Stromal Tumor Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Gastrointestinal Stromal Tumor Global Market Report 2025

Proud Members Of

Gastrointestinal Stromal Tumor Market Definition

A gastrointestinal stromal tumor (GIST) is a type of rare, non-epithelial tumor that originates in the gastrointestinal (GI) tract. These are most commonly developed in the stomach or the small intestine, but they can occur anywhere along the GI tract, from the esophagus to the rectum.

The main treatment types of gastrointestinal stromal tumors are chemotherapy, targeted therapy, and others. Chemotherapy is a medical treatment that uses powerful drugs to target and kill rapidly dividing cells in the body, including cancer cells. It is indicated for various indications such as stomach, small intestine, and others, by different end-users including hospitals, clinics, specialized cancer treatment centers, and others.

Gastrointestinal Stromal Tumor Market Segmentation

The gastrointestinal stromal tumor market covered in this report is segmented –

1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types

2) By Indication: Stomach, Small Intestine, Others Indications

3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens

2) By Targeted Therapy: tyrosine kinase inhibitors, Other Targeted Agents

3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies

Gastrointestinal Stromal Tumor Market Size and growth rate 2025 to 2029: Graph

Gastrointestinal Stromal Tumor Market Size 2025 And Growth Rate

The gastrointestinal stromal tumor market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increased awareness and early diagnosis, emergence of targeted therapies, enhanced surgical techniques, development of personalized medicine, improvements in supportive care.

Gastrointestinal Stromal Tumor Market Growth Forecast

The gastrointestinal stromal tumor market size is expected to see strong growth in the next few years. It will grow to $1.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continued research and drug development, rise in patient-centric healthcare, integration of precision medicine in clinical practice, increasing access to targeted therapies, expanding genomic profiling capabilities. Major trends in the forecast period include growing collaboration in research and development, advancements in diagnostic technologies, collaborative research and clinical trials, increased focus on early detection and diagnosis, exploration of combination therapies.

Book your 30 minutes free consultation with our research experts

Gastrointestinal Stromal Tumor Market Driver: Growing Incidence Of Stomach Cancer To Boost The Market

The growing incidence of stomach cancer is expected to propel the growth of the gastrointestinal stromal tumor market going forward. Stomach cancer refers to the uncontrolled growth and multiplication of malignant cells in the lining of the stomach. while gastrointestinal stromal tumors (GISTs) can occur in the stomach, they are distinct from stomach cancer. When two separate tumors collide and merge into one, patients with GISTs have been found to have an increased risk of developing additional cancers, including small bowel adenocarcinoma. For instance, in January 2024, according to the American Cancer Society, a US-based professional organization, around 26,890 new cases of stomach cancer and 10,880 deaths are anticipated in the U.S. for 2024, accounting for 1.5% of all new cancer diagnoses. Therefore, the growing incidence of stomach cancer is driving the growth of the gastrointestinal stromal tumor market.

Gastrointestinal Stromal Tumor Market Driver: Rising Demand For Precision Medicine Boost The Market

The rising demand for precision medicine is expected to propel the growth of the gastrointestinal stromal tumor market going forward. Precision medicine is an approach to medical treatment that customizes healthcare decisions, interventions, and therapies based on individual patient characteristics, such as genetics and lifestyle. Precision medicine for gastrointestinal stromal tumors involves molecular profiling to identify specific mutations, guiding targeted therapies like imatinib, enhancing treatment efficacy, and minimizing side effects through tailored interventions. For instance, in February 2023, according to a report by the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, personalized medicines accounted for 35% of newly approved NMEs in 2021, and with 12 new approvals in 2022, they have maintained a consistent share of at least a quarter of new drug approvals over the past eight years, reflecting a significant increase from under 10% a decade ago. Therefore, the rising demand for precision medicine is driving the growth of the gastrointestinal stromal tumor market.

Global Gastrointestinal Stromal Tumor Market Major Players

Major companies operating in the gastrointestinal stromal tumor market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Advenchen Laboratories LLC, Arog Pharmaceuticals Inc., AB Sciences S.A.

Global Gastrointestinal Stromal Tumor Market Trend: Increasing Focus On Drug Approvals To Drive The Revenues

Major companies operating in the gastrointestinal stromal tumor market are innovating new drugs such as QINLOCK (Ripretinib) to meet larger customer bases, more sales, and increased revenue. QINLOCK (Ripretinib) is a prescription medicine used to treat advanced gastrointestinal stromal tumor (GIST). For instance, in January 2024, according to the US Food and Drug Administration (FDA) a US-based federal agency, the CDER novel drug approvals in 2022 was 37 which increased up to 55 drugs in 2023. CDER identified 20 out of the 55 novel drugs (36%) approved in 2023 as first-in-class.

Gastrointestinal Stromal Tumor Market Merger And Acquisition: Immatics Partnered With Bristol Myers Squibb

In June 2022, Immatics N.V., a Germany-based biotechnology company partnered with Bristol Myers Squibb to create programs for gamma delta allogeneic cell therapy. The goal of this partnership is to create cutting-edge cancer immunotherapies with the potential to enhance the treatment of different cancers. Bristol Myers Squibb is a US-based pharmaceutical company. It develops treatments related to gastrointestinal stromal tumors (GISTs).

Regional Outlook For The Global Gastrointestinal Stromal Tumor Market

North America was the largest region in the gastrointestinal stromal tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gastrointestinal stromal tumor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Gastrointestinal Stromal Tumor Market?

The gastrointestinal stromal tumor market includes revenues earned by entities by providing services such as diagnostic services, pathology services, pathology services, and pathology services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal stromal tumor market also includes sales of targeted therapy, chemotherapy, radiation therapy. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gastrointestinal Stromal Tumor Industry?

The gastrointestinal stromal tumor market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal stromal tumor market statistics, including gastrointestinal stromal tumor industry global market size, regional shares, competitors with a gastrointestinal stromal tumor market share, detailed gastrointestinal stromal tumor market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal stromal tumor industry. This gastrointestinal stromal tumor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gastrointestinal Stromal Tumor Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.37 billion
Revenue Forecast In 2034	$1.82 billion
Growth Rate	CAGR of 7.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types 2) By Indication: Stomach, Small Intestine, Others Indications 3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users Subsegments: 1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens 2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents 3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Advenchen Laboratories LLC, Arog Pharmaceuticals Inc., AB Sciences S.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Gastrointestinal Stromal Tumor Market Characteristics

3. Gastrointestinal Stromal Tumor Market Trends And Strategies

4. Gastrointestinal Stromal Tumor Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gastrointestinal Stromal Tumor Growth Analysis And Strategic Analysis Framework

5.1. Global Gastrointestinal Stromal Tumor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gastrointestinal Stromal Tumor Market Growth Rate Analysis

5.4. Global Gastrointestinal Stromal Tumor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gastrointestinal Stromal Tumor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gastrointestinal Stromal Tumor Total Addressable Market (TAM)

6. Gastrointestinal Stromal Tumor Market Segmentation

6.1. Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemotherapy

Targeted Therapy

Other Treatment Types

6.2. Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stomach

Small Intestine

Others Indications

6.3. Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Specialized Cancer Treatment Centers

Other End-Users

6.4. Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Traditional Chemotherapy Agents

Combination Chemotherapy Regimens

6.5. Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tyrosine Kinase Inhibitors

Other Targeted Agents

6.6. Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Surgery

Radiation Therapy

Clinical Trials For Novel Therapies

7. Gastrointestinal Stromal Tumor Market Regional And Country Analysis

7.1. Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastrointestinal Stromal Tumor Market

8.1. Asia-Pacific Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastrointestinal Stromal Tumor Market

9.1. China Gastrointestinal Stromal Tumor Market Overview

9.2. China Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastrointestinal Stromal Tumor Market

10.1. India Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastrointestinal Stromal Tumor Market

11.1. Japan Gastrointestinal Stromal Tumor Market Overview

11.2. Japan Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastrointestinal Stromal Tumor Market

12.1. Australia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastrointestinal Stromal Tumor Market

13.1. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastrointestinal Stromal Tumor Market

14.1. South Korea Gastrointestinal Stromal Tumor Market Overview

14.2. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastrointestinal Stromal Tumor Market

15.1. Western Europe Gastrointestinal Stromal Tumor Market Overview

15.2. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastrointestinal Stromal Tumor Market

16.1. UK Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastrointestinal Stromal Tumor Market

17.1. Germany Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastrointestinal Stromal Tumor Market

18.1. France Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastrointestinal Stromal Tumor Market

19.1. Italy Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastrointestinal Stromal Tumor Market

20.1. Spain Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastrointestinal Stromal Tumor Market

21.1. Eastern Europe Gastrointestinal Stromal Tumor Market Overview

21.2. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastrointestinal Stromal Tumor Market

22.1. Russia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastrointestinal Stromal Tumor Market

23.1. North America Gastrointestinal Stromal Tumor Market Overview

23.2. North America Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastrointestinal Stromal Tumor Market

24.1. USA Gastrointestinal Stromal Tumor Market Overview

24.2. USA Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastrointestinal Stromal Tumor Market

25.1. Canada Gastrointestinal Stromal Tumor Market Overview

25.2. Canada Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastrointestinal Stromal Tumor Market

26.1. South America Gastrointestinal Stromal Tumor Market Overview

26.2. South America Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastrointestinal Stromal Tumor Market

27.1. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastrointestinal Stromal Tumor Market

28.1. Middle East Gastrointestinal Stromal Tumor Market Overview

28.2. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastrointestinal Stromal Tumor Market

29.1. Africa Gastrointestinal Stromal Tumor Market Overview

29.2. Africa Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastrointestinal Stromal Tumor Market Competitive Landscape And Company Profiles

30.1. Gastrointestinal Stromal Tumor Market Competitive Landscape

30.2. Gastrointestinal Stromal Tumor Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gastrointestinal Stromal Tumor Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc

31.2. Bristol-Myers Squibb Company

31.3. Sanofi S.A.

31.4. AstraZeneca plc

31.5. Eli Lilly and Company

31.6. Daiichi Sankyo Co. Ltd.

31.7. Eisai Co. Ltd.

31.8. Sun Pharmaceutical Industries Limited

31.9. Jiangsu Hengrui Medicine Co. Ltd.

31.10. Exelixis Inc.

31.11. NATCO Pharma Ltd.

31.12. Blueprint Medicines Corporation

31.13. Array BioPharma Inc.

31.14. Deciphera Pharmaceuticals Inc.

31.15. Ono Pharmaceutical Co. Ltd.

32. Global Gastrointestinal Stromal Tumor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Stromal Tumor Market

34. Recent Developments In The Gastrointestinal Stromal Tumor Market

35. Gastrointestinal Stromal Tumor Market High Potential Countries, Segments and Strategies

35.1 Gastrointestinal Stromal Tumor Market In 2029 - Countries Offering Most New Opportunities

35.2 Gastrointestinal Stromal Tumor Market In 2029 - Segments Offering Most New Opportunities

35.3 Gastrointestinal Stromal Tumor Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: F. Hoffmann-La Roche AG Financial Performance

Table 79: Bayer AG Financial Performance

Table 80: Novartis AG Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: F. Hoffmann-La Roche AG Financial Performance

Figure 79: Bayer AG Financial Performance

Figure 80: Novartis AG Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Tumor Ablation Therapy Devices Global Market Report 2025 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies), By Treatment (Surgical, Laparoscopic, Percutaneous), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End User (Hospitals, Oncology Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Embolization Devices Global Market Report 2025 – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Tumor Profiling Global Market Report 2025 – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types ), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies), By Process Type (Genomics, Proteomics, Epigenetics, Metabolomics, Other Types), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Circulating Tumor Cells Global Market Report 2025 – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Specimen (Blood, Bone Marrow, Other Body Fluids), By Application (Clinical Or Liquid Biopsy, Research) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Intratumoral Cancer Therapies Global Market Report 2025 – By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines ), By Application (Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Other Applications ), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Solid Tumor Cancer Treatment Global Market Report 2025 – By Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Surgical Procedures), By Application (Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Applications ), By End-Users (Hospitals, Research Institutes, Homecare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Infiltrating Lymphocytes Global Market Report 2025 – By Anatomy (CD3, CD8, CD16, CD56, CD4, CD57, CD169, CD68, FOXP3), By Component (T-Cells, B-Cells, Natural Killer Cells), By Application (Melanoma, Cervical Cancer, Ovarian Cancer, Other Applications), By End-User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025 – By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous Injection ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Gastrointestinal Stromal Tumor market?

How will the Gastrointestinal Stromal Tumor market drivers and restraints affect the market dynamics? What forces will shape the Gastrointestinal Stromal Tumor industry going forward?

The Gastrointestinal Stromal Tumor market major growth driver - Growing Incidence Of Stomach Cancer To Boost The Market. For further insights on the Gastrointestinal Stromal Tumor market, request a sample here

What is the forecast market size or the forecast market value of the Gastrointestinal Stromal Tumor market?

The Gastrointestinal Stromal Tumor market size has grown strongly in recent years. The gastrointestinal stromal tumor market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increased awareness and early diagnosis, emergence of targeted therapies, enhanced surgical techniques, development of personalized medicine, improvements in supportive care. The gastrointestinal stromal tumor market size is expected to see strong growth in the next few years. It will grow to $1.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continued research and drug development, rise in patient-centric healthcare, integration of precision medicine in clinical practice, increasing access to targeted therapies, expanding genomic profiling capabilities. Major trends in the forecast period include growing collaboration in research and development, advancements in diagnostic technologies, collaborative research and clinical trials, increased focus on early detection and diagnosis, exploration of combination therapies. For further insights on the Gastrointestinal Stromal Tumor market, request a sample here

How is the Gastrointestinal Stromal Tumor market segmented?

The gastrointestinal stromal tumor market covered in this report is segmented –
1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
2) By Indication: Stomach, Small Intestine, Others Indications
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users Subsegments:
1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens
2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents
3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies For further insights on the Gastrointestinal Stromal Tumor market, request a sample here

Which region has the largest share of the Gastrointestinal Stromal Tumor market? What are the other regions covered in the report?

North America was the largest region in the gastrointestinal stromal tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Gastrointestinal Stromal Tumor market, request a sample here.

Who are the major players in the Gastrointestinal Stromal Tumor market?

What are the key trends in the Gastrointestinal Stromal Tumor market?

Major trends in the Gastrointestinal Stromal Tumor market include Increasing Focus On Drug Approvals To Drive The Revenues. For further insights on the Gastrointestinal Stromal Tumor market, request a sample here.

What are the major opportunities in the Gastrointestinal Stromal Tumor market? What are the strategies for the Gastrointestinal Stromal Tumor market?

For detailed insights on the major opportunities and strategies in the Gastrointestinal Stromal Tumor market, request a sample here.

How does the Gastrointestinal Stromal Tumor market relate to the overall economy and other similar markets?

For detailed insights on Gastrointestinal Stromal Tumor's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Gastrointestinal Stromal Tumor industry?

For detailed insights on the mergers and acquisitions in the Gastrointestinal Stromal Tumor industry, request a sample here.

What are the key dynamics influencing the Gastrointestinal Stromal Tumor market growth? SWOT analysis of the Gastrointestinal Stromal Tumor market.

For detailed insights on the key dynamics influencing the Gastrointestinal Stromal Tumor market growth and SWOT analysis of the Gastrointestinal Stromal Tumor industry, request a sample here.